Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
About Zhejiang Cheng Yi Pharmaceutical Co., Ltd.
Categories
-
CN
-
2015On CPHI since
Company types
Meet us at
CPHI & PMEC China 2025
Shanghai New International Expo Center
24 Jun 2025 - 26 Jun 2025
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (13)
-
Product Azathioprine
Approved by US FDA, TGA, MHRA and EMA, CEP certified -
Product Capecitabine
DMF filed with US FDA -
Product Mercaptopurine
Approved by US FDA, TGA, and EMA -
Product Montelukast sodium
Under development
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. Resources (1)
-
News A Comprehensive Pharmaceutical Enterprise with Multi-Field
We are committed to the export of several API and intermediates, such as Azathioprine, Mercaptopurine, Ribavirin etc.
Recently Visited
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance